Urology Division Chief Gerald Andriole, MD, discusses clinical research to advance treatment of urologic disease.

Research has always been an important focus of the Division of Urologic Surgery at Washington University School of Medicine.

From the earliest days, there has been an understanding that an effective doctor must be a good scientist as well as a compassionate and understanding person. In keeping with that principle, the division’s surgeons continually undertake projects that are at the forefront of urologic research on topics such as prostate cancer screening, treatment of benign prostate enlargement, cellular research, outcomes research, female urinary incontinence and pediatric urology.

In the area of prostate cancer screening, the division is participating in the Prostate, Lung, Colon and Ovarian (PLCO) Cancer Screening Trial, which is funded by the National Institutes of Health (NIH) and National Cancer Institute (NCI). Gerald L. Andriole, Jr., M.D., the Robert K. Royce Distinguished Professor of Urologic Surgery and chief of the Division of Urologic Surgery, is chairman of the Prostate Subcommittee for the trial, which has made important recommendations in screening for prostate cancer. In addition to the PLCO trial, Dr. Andriole was involved in a clinical trial that found the drug dutasteride reduced the risk of prostate cancer in men with an increased risk of the disease.

Faculty members also perform basic research in the areas of interstitial cystitis and overactive bladder.

Learn more about:

Volunteer for Health
Department of Surgery research